D&CVD Symposium: The cardio-renal-metabolic challenge in type 2 diabetes
Tuesday, 20 September 2022, 11:45 - 13:30, Koch Hall
Chairs: Doina Catrinoiu, Romania, Jan Škrha, Czech Republic
Eberhard Standl, Germany: Cardio-renal-metabolic interplay: Emerging notions and basic clinical treatment strategies
Paul Valensi, France: SGLT2-inhibitors: Key treatment option beyond type 2 diabetes regardless of cardiac ejection fraction
Oliver Schnell, Germany: Finerenone – New magic drug reducing cardio-renal disease?
Mahmoud Ibrahim, USA: Envisaging a new interdisciplinary subspecialty training in medicine for dealing with the cardio-renal-metabolic challenge in type 2 diabetes
All chairs and speakers together with Lars Rydén, Sweden, Per-Henrik Groop, Finland, Nebojsa Lalic, Serbia, Baruch Itzhak, Israel, Dario Rahelic, Croatia: Interdisciplinary panel discussion with diabetologists, cardiologists, nephrologists, primary care physicians